在早产婴儿监测维生素D补充剂的高初始剂量 (HIDVID试验):随机对照研究的研究协议
Dominika Paw1, Renata Bokiniec1, Alicja Kołodziejczyk-Nowotarska1
1Department of Neonatology and Neonatal Intensive Care, Medical University of Warsaw, 00-315 Warsaw, Poland.
Nutrients
|March 13, 2024
概括
这项研究调查了对早产婴儿进行监测的维生素D补充剂. 较高的初始剂量可以减少新生儿败血症和骨病,改善婴儿健康结果.
科学领域:
- 新生儿科学 新生儿科学
- 儿科内分泌学 儿科内分泌学
- 营养科学 营养科学
背景情况:
- 维生素D缺乏与早产婴儿的骨疾病和免疫问题有关.
- 过早出生的婴儿 (怀孕24-32周) 面临这些并发症的高风险.
- 早期评估维生素D状况对于干预至关重要.
研究的目的:
- 评估在早产婴儿中监测的维生素D补充剂的疗效.
- 为了确定是否高初始剂量维生素D可以减少新生儿败血症和代谢性骨病.
- 为了比较监测的补充剂与标准剂量协议.
主要方法:
- 随机对照试验涉及早产婴儿 (怀孕24-32周).
- 测量25-氧维生素D,副甲状腺激素,和介质素-6的水平.
- 补充组:监测 (1000 IU/天最初) 与控制 (250-500 IU/天).
- 监测持续到怀孕后35周的时间.
主要成果:
- 主要终点:28天25-氧维生素D缺乏/低于最佳水平的婴儿百分比.
- 二级终点:败血症的发生率,骨质疏松症,甲状腺功能障碍和IL-6水平.
- 在怀孕35周后对维生素D水平的分析.
结论:
- 监控的维生素D补充剂可能更有效地达到早产婴儿的最佳水平.
- 高初始维生素D剂量需要进一步研究,以预防新生儿并发症.
- 优化维生素D状态对于早产婴儿的发育和健康至关重要.
相关概念视频
Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...


